"MAC Clinical Research is a healthcare organisation dedicated to the development of new and improved treatments through clinical trials."

During the past decade, MAC Clinical Research Manchester (Early Phase Unit), Neuroscience Centre of Excellence conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "MAC Clinical Research Manchester (Early Phase Unit), Neuroscience Centre of Excellence" #1 collaborator was "ERT: Clinical Trial Technology Solutions" with 1 trials as a collaborator, "Hammersmith Medicines Research" with 1 trials as a collaborator and "MAC Clinical Research" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "MAC Clinical Research Manchester (Early Phase Unit), Neuroscience Centre of Excellence" are "Covid19" (1 trials), "Migraines" (1 trials) and "Opiate Withdrawal Syndrome" (1 trials). Many other conditions were trialed in "MAC Clinical Research Manchester (Early Phase Unit), Neuroscience Centre of Excellence" in a lesser frequency.

Most popular intervention types in "MAC Clinical Research Manchester (Early Phase Unit), Neuroscience Centre of Excellence" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "DMX-1002" (1 trials), "Ivermectin" (1 trials), "Part A: TRV250-20mg/ml" (1 trials) and "Part B: TRV250 Dose 1" (1 trials). Other intervention names were less common.

The vast majority of trials in "MAC Clinical Research Manchester (Early Phase Unit), Neuroscience Centre of Excellence" are 2 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "MAC Clinical Research Manchester (Early Phase Unit), Neuroscience Centre of Excellence". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in MAC Clinical Research Manchester (Early Phase Unit), Neuroscience Centre of Excellence, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in MAC Clinical Research Manchester (Early Phase Unit), Neuroscience Centre of Excellence, 3 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".